OTC : ATBPF

Antibe Therapeutics Inc. — Earnings Estimates

$0.2156 USD

$0.0 (-0.19%)

Volume
17.94K
Average Volume
9.5K
Market Capitalization
$11.43M
P/E Ratio
-0.80
Dividend Yield
0.00%
Price Target
Year High
$0.22
Year Low
$0.19
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$15.03

Annual earnings financials

ATBPF financial data with annual/quarterly toggle

ATBPF GAAP EPS - Annual & Quarterly

ATBPF Sales Revenue - Annual & Quarterly

ATBPF Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

ATBPF Estimated and Actual Revenue by Quarter
ATBPF Estimated and Actual EPS by Quarter
ATBPF Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2025-03-31 0 - - - - - -
2024-12-31 0 - - - - - -
2024-09-30 0 - - - - - -
2024-06-30 0 - - - - - -
2024-03-31 0 - - - - - -
2023-12-31 0 - - - - - -
ATBPF Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2025-03-31 0 -3.66M -3.66M -3.66M - - -
2024-12-31 0 -3.68M -3.68M -3.68M - - -
2024-09-30 0 -3.7M -3.7M -3.7M - - -
2024-06-30 0 -4.21M -4.21M -4.21M - - -
2024-03-31 0 - - - - - -
2023-12-31 0 - - - - - -
ATBPF Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2025-03-31 0 - - - 1 -0.06959775 -0.06959775 -0.06959775
2024-12-31 0 - - - 1 -0.06995301 -0.06995301 -0.06995301
2024-09-30 0 - - - 1 -0.07020753 -0.07020753 -0.07020753
2024-06-30 0 - - - 1 -0.07994618 -0.07994618 -0.07994618
2024-03-31 0 - - - 0 0 0 0
2023-12-31 0 - - - 0 0 0 0